Pharma Friday – August 21, 2026

Published on August 21, 2026

An Endocrine News roundup of the week’s pharmaceutical news, breakthroughs, and general information. * Amylyx Pharmaceuticals Announces Positive Topline Results from Phase 3 LUCIDITY Clinical Trial of Avexitide in Post-Bariatric Hypoglycemia On August 18, Amylyx Pharmaceuticals, Inc., announced positive topline results from LUCIDITY, a 78-participant, multicenter, randomized, double-blind, placebo-controlled Phase 3 clinical trial evaluating the […]

The post Pharma Friday – August 21, 2026 appeared first on Endocrine News.

Continue reading on website
Other news

Star Power 2026: Q&A with Lila Dabill, PhD

August 21, 2026
Early-career and in-training members get their chances to shine brightly at the Rising Star Power Talks that take place at ENDO each year. Endocrine News caught up with this year’s Basic Science winner, Lila Dabill, a PhD student at Washington University in St. Louis, Mo., to learn more about her research, future plans, the impact […]The post Star Power 2026: Q&A with Lila Dabill, PhD appeared fir